Enhanced Acute Muscle Activation in ALS Patients Following Liposomal Curcumin, Resveratrol, and Dutasteride...

Area of Science:

• Neuroscience
• Neuromuscular Disorders
• Pharmacology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease impacting motor neurons, leading to muscle weakness and loss of motor control.
• Current therapeutic options for ALS are limited, highlighting the need for novel interventions targeting muscular electrical activity and function.
• Polyphenolic antioxidants like curcumin and resveratrol, along with dutasteride, are being explored for their potential neuroprotective and muscle-modulating effects.

Purpose of the Study:

• To evaluate the acute effects of a combined therapeutic approach on electrical muscle activation in patients diagnosed with ALS.
• To assess changes in basal muscle activation and fasciculations following a 2-month intervention with liposomal curcumin, resveratrol, and dutasteride.

Main Methods:

• A randomized controlled trial was conducted with patients diagnosed with bulbar and spinal ALS.
• The intervention group (IG) received an oral combination of liposomal curcumin, resveratrol, and dutasteride, while the control group (CG) received a placebo for two months.
• Surface electromyography (sEMG) was used to measure basal muscle electrical activity and fasciculations in the biceps brachii, triceps brachii, rectus femoris, and tibialis anterior muscles before and after the intervention.

Main Results:

• The intervention group demonstrated a significant increase in basal electrical muscle activity in both right and left hemibody muscles, with less variability post-treatment.
• Fasciculations showed increased total activation in upper muscles for the intervention group and in lower muscles for the control group.
• Muscle activation patterns remained stable in the intervention group, contrasting with observed variations in the control group.

Conclusions:

• The combination of liposomal curcumin, resveratrol, and dutasteride may positively influence electrical muscle activity in ALS patients.
• This therapeutic combination appears to stabilize muscle activation patterns and potentially modulate fasciculations, warranting further investigation.
• Further research is needed to confirm these findings and explore the long-term efficacy and safety of this combined treatment for ALS.